Company intelligence / Profile preview
Kannavis Biotech Corp.
British Columbia, Canada
- Ownership
- Private
- Development stage
- Other
01
Overview
Kannavis Biotech is developing live biotherapeutic products designed to modulate the microbiome for therapeutic benefit. The company's flagship program, KAN-001, is in preclinical development (75% completed for checkpoint refractory cancers, 25% completed for checkpoint naïve cancers) as a synergistic therapy to prime the immune system and increase immunotherapy response rates. KAN-004, also in preclinical development, targets checkpoint inhibitor-induced colitis[2].
- Therapeutic areas
- OncologyNeurologyGastroenterology
- Modalities
- Live biotherapeutic product therapyMicrobial therapy
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Beleave Inc. (50/50 operating expenditure and revenue partnership for indoor cannabis growing facilities in British Columbia)[1][3][9]University of Texas MD Anderson Cancer Center (research partnership on immunotherapy-resistant cancer treatments)[2]
Beyond the preview
Go deeper on Kannavis Biotech Corp..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kannavis Biotech Corp..